☰

Enrique A. Mesri - Publications

Affiliations: 
Microbiology and Immunology (Medicine) University of Miami, Coral Gables, FL 
Area:
Microbiology Biology, Oncology
Tree Info Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Naipauer J, Mesri EA. The Kaposi's sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis. Trends in Molecular Medicine. 29: 188-200. PMID 36635149 DOI: 10.1016/j.molmed.2022.12.003  0.32
2022 Schlesinger M, McDonald C, Ahuja A, Alvarez Canete CA, Nuñez Del Prado Z, Naipauer J, Lampidis T, Mesri EA. Glucose and mannose analogs inhibit KSHV replication by blocking N-glycosylation and inducing the unfolded protein response. Journal of Medical Virology. e28314. PMID 36380418 DOI: 10.1002/jmv.28314  0.326
2022 Sapochnik D, Raimondi AR, Medina V, Naipauer J, Mesri EA, Coso O. A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes. Frontiers in Oncology. 12: 890825. PMID 36212441 DOI: 10.3389/fonc.2022.890825  0.392
2021 Méndez-Solís O, Bendjennat M, Naipauer J, Theodoridis PR, Ho JJD, Verdun RE, Hare JM, Cesarman E, Lee S, Mesri EA. Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis. Cell Reports. 37: 110144. PMID 34965440 DOI: 10.1016/j.celrep.2021.110144  0.385
2020 Medina MV, D Agostino A, Ma Q, Eroles P, Cavallin L, Chiozzini C, Sapochnik D, Cymeryng C, Hyjek E, Cesarman E, Naipauer J, Mesri EA, Coso OA. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Plos Pathogens. 16: e1009006. PMID 33057440 DOI: 10.1371/journal.ppat.1009006  0.78
2020 Naipauer J, Salyakina D, Journo G, Rosario S, Williams S, Abba M, Shamay M, Mesri EA. High-throughput sequencing analysis of a "hit and run" cell and animal model of KSHV tumorigenesis. Plos Pathogens. 16: e1008589. PMID 32603362 DOI: 10.1371/Journal.Ppat.1008589  0.493
2019 Naipauer J, Cavallin LE, Mesri EA. Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit. Bio-Protocol. 9. PMID 32864391 DOI: 10.21769/bioprotoc.3216  0.78
2019 Naipauer J, Rosario S, Gupta S, Premer C, Méndez-Solís O, Schlesinger M, Ponzinibbio V, Jain V, Gay L, Renne R, Chan HL, Morey L, Salyakina D, Abba M, Williams S, ... ... Mesri EA, et al. PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment. Plos Pathogens. 15: e1008221. PMID 31881074 DOI: 10.1371/Journal.Ppat.1008221  0.337
2019 López-Rodríguez DM, Kirillov V, Krug LT, Mesri EA, Andreansky S. A role of hypoxia-inducible factor 1 alpha in Mouse Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency. Plos Pathogens. 15: e1008192. PMID 31809522 DOI: 10.1371/Journal.Ppat.1008192  0.443
2019 Naipauer J, Cavallin L, Mesri E. Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit Bio-Protocol. 9. DOI: 10.21769/bioprotoc.3216  0.735
2018 Rosario SA, Santiago GE, Mesri EA, Verdun RE. Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination. Frontiers in Microbiology. 9: 3119. PMID 30619193 DOI: 10.3389/Fmicb.2018.03119  0.421
2018 Cavallin LE, Ma Q, Naipauer J, Gupta S, Kurian M, Locatelli P, Romanelli P, Nadji M, Goldschmidt-Clermont PJ, Mesri EA. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. Plos Pathogens. 14: e1007175. PMID 29985958 DOI: 10.1371/Journal.Ppat.1007175  0.801
2018 Cavallin L, Ma Q, Naipauer J, Romanelli P, Goldschmidt P, Mesri E. 145 Kshv-dependent activation of PDGF receptor-α signaling is an oncogenic driver in kaposi's sarcoma Journal of Investigative Dermatology. 138: S25. DOI: 10.1016/J.Jid.2018.03.150  0.339
2015 Liu G, Yu FX, Kim YC, Meng Z, Naipauer J, Looney DJ, Liu X, Gutkind JS, Mesri EA, Guan KL. Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 34: 3536-46. PMID 25195862 DOI: 10.1038/Onc.2014.281  0.457
2014 Cavallin LE, Goldschmidt-Clermont P, Mesri EA. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS. Plos Pathogens. 10: e1004154. PMID 25010730 DOI: 10.1371/Journal.Ppat.1004154  0.738
2014 Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host & Microbe. 15: 266-82. PMID 24629334 DOI: 10.1016/J.Chom.2014.02.011  0.353
2014 Croci DO, Cerliani JP, Dalotto-Moreno T, Méndez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, García-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 156: 744-58. PMID 24529377 DOI: 10.1016/J.Cell.2014.01.043  0.407
2014 Ashlock BM, Ma Q, Issac B, Mesri EA. Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. Plos One. 9: e87324. PMID 24489895 DOI: 10.1371/Journal.Pone.0087324  0.81
2013 Mesri EA, Cavallin LE, Ashlock BM, Leung HJ, Ma Q, Goldschmidt-Clermont PJ. Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis. Immunologic Research. 57: 159-65. PMID 24203444 DOI: 10.1007/S12026-013-8458-Z  0.776
2013 Bhatt S, Ashlock BM, Natkunam Y, Sujoy V, Chapman JR, Ramos JC, Mesri EA, Lossos IS. CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. Blood. 122: 1233-42. PMID 23838350 DOI: 10.1182/Blood-2013-01-481713  0.798
2013 Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. The Journal of Clinical Investigation. 123: 2616-28. PMID 23635777 DOI: 10.1172/Jci64503  0.786
2013 Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, Mesri EA. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Antioxidants & Redox Signaling. 18: 80-90. PMID 22746102 DOI: 10.1089/Ars.2012.4584  0.767
2012 Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A, Rabinovich GA. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. The Journal of Experimental Medicine. 209: 1985-2000. PMID 23027923 DOI: 10.1084/Jem.20111665  0.785
2011 Salomón DG, Grioli SM, Buschiazzo M, Mascaró E, Vitale C, Radivoy G, Perez M, Fall Y, Mesri EA, Curino AC, Facchinetti MM. Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity. Acs Medicinal Chemistry Letters. 2: 503-8. PMID 24900339 DOI: 10.1021/Ml200034W  0.305
2011 Mesri EA, Cesarman E. Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. Cell Host & Microbe. 10: 529-31. PMID 22177556 DOI: 10.1016/J.Chom.2011.11.008  0.402
2011 Daftarian P, Chowdhury R, Ames P, Wei C, King AD, de Rivero Vaccari JP, Dillon L, Price J, Leung H, Ashlock B, Mesri E, Perez V, Züchner S, Reiser J, Lemmon V, et al. In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma (2005). 30: 409-18. PMID 22008067 DOI: 10.1089/Hyb.2010.0120  0.741
2011 Bhatt S, Ashlock B, Natkunam Y, Ramos JC, Mesri E, Lossos IS. Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL), Blood. 118: 3728-3728. DOI: 10.1182/Blood.V118.21.3728.3728  0.796
2011 Bhatt S, Ashlock B, Toomey N, Mesri E, Ramos JC, Lossos IS. Synergistic Preclinical Activity of Bortezomib with Suberoylanilide Hydroxamic Acid (SAHA) in Primary Effusion Lymphoma (PEL) Blood. 118: 1650-1650. DOI: 10.1182/Blood.V118.21.1650.1650  0.811
2011 Leung HJ, Duran M, Kurtoglu M, Lampidis TJ, Mesri EA. Abstract 2725: 2-Deoxyglucose inhibits KSHV replication under normoxic conditions Cancer Research. 71: 2725-2725. DOI: 10.1158/1538-7445.Am2011-2725  0.471
2011 Cavallin LE, Ma Q, Goldschmidt-Clermont PJ, Mesri EA. Abstract 2710: KSHV-induced PDGF signaling dyregulation drives a Rac1 and ROS-mediated paracrine tumorigenic mechanism necessary for Kaposi's sarcoma Cancer Research. 71: 2710-2710. DOI: 10.1158/1538-7445.Am2011-2710  0.809
2010 Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nature Reviews. Cancer. 10: 707-19. PMID 20865011 DOI: 10.1038/Nrc2888  0.487
2010 Sarosiek KA, Cavallin LE, Bhatt S, Toomey NL, Natkunam Y, Blasini W, Gentles AJ, Ramos JC, Mesri EA, Lossos IS. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 107: 13069-74. PMID 20615981 DOI: 10.1073/Pnas.1002985107  0.792
2010 Cavallin LE, Ma Q, Goldschmidt-Clermont P, Mesri EA. KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi's sarcoma Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A49  0.806
2009 Muratori C, Cavallin LE, Krätzel K, Tinari A, De Milito A, Fais S, D'Aloja P, Federico M, Vullo V, Fomina A, Mesri EA, Superti F, Baur AS. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host & Microbe. 6: 218-30. PMID 19748464 DOI: 10.1016/J.Chom.2009.06.009  0.763
2009 Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 8683-8. PMID 19429708 DOI: 10.1073/Pnas.0812688106  0.802
2007 Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell. 11: 245-58. PMID 17349582 DOI: 10.1016/J.Ccr.2007.01.015  0.798
2007 D'Agostino Mutlu A, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KMD, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma (DOI:10.1016/j.ccr.2007.01.015) Cancer Cell. 11: 471. DOI: 10.1016/J.Ccr.2007.04.013  0.782
2006 Cesarman E, Mesri EA. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Current Topics in Microbiology and Immunology. 312: 263-87. PMID 17089801 DOI: 10.1007/978-3-540-34344-8_10  0.476
2006 Cesarman E, Mesri EA. Pathogenesis of viral lymphomas. Cancer Treatment and Research. 131: 49-88. PMID 16704166 DOI: 10.1007/978-0-387-29346-2_2  0.346
2003 Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell. 3: 131-43. PMID 12620408 DOI: 10.1016/S1535-6108(03)00024-2  0.336
2001 Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood. 97: 729-36. PMID 11157491 DOI: 10.1182/blood.V97.3.729  0.301
2000 Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? Journal of Experimental Medicine. 191: 417-421. PMID 10662787 DOI: 10.1084/Jem.191.3.417  0.305
1999 Cesarman E, Mesri EA. Virus-associated lymphomas. Current Opinion in Oncology. 11: 322-32. PMID 10505767 DOI: 10.1097/00001622-199909000-00002  0.308
1998 Geras-Raaka E, Arvanitakis L, Bais C, Cesarman E, Mesri EA, Gershengorn MC. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. The Journal of Experimental Medicine. 187: 801-6. PMID 9480990 DOI: 10.1084/Jem.187.5.801  0.347
1998 Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391: 86-9. PMID 9422510 DOI: 10.1038/34193  0.407
1996 Arvanitakis L, Mesri E, Nador R, Said J, Asch A, Knowles D, Cesarman E. Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus Blood. 88: 2648-2654. DOI: 10.1182/Blood.V88.7.2648.Bloodjournal8872648  0.467
Show low-probability matches.